Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drugs Used in Upper Respiratory Disorders: Overview01:16

Drugs Used in Upper Respiratory Disorders: Overview

1.0K
Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
1.0K
Chronic Pharyngitis01:23

Chronic Pharyngitis

16.8K
Chronic pharyngitis refers to persistent inflammation of the pharyngial mucosa.
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
16.8K
Allergic Reactions: Anaphylaxis01:30

Allergic Reactions: Anaphylaxis

293
Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin,...
293
Upper Respiratory Drugs: Decongestants01:27

Upper Respiratory Drugs: Decongestants

1.4K
Decongestants are a class of medications used primarily to alleviate nasal congestion, a common symptom resulting from allergies, colds, sinusitis, and other upper respiratory tract infections. These drugs work by activating α-adrenergic receptors, constricting small blood vessels in the nasal membranes. This action results in the opening of clogged nasal passages, thereby facilitating sinus drainage and relieving congestion.
Most decongestants are readily available over-the-counter in...
1.4K
Common Respiratory Disorders01:31

Common Respiratory Disorders

1.8K
Respiratory disorders, a prevalent health concern globally, are generally divided into two primary categories: upper and lower respiratory tract disorders. The categorization is based on the area of the respiratory system they affect.
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
1.8K
Epistaxis01:30

Epistaxis

864
Epistaxis, or nosebleeds, occurs when small, swollen blood vessels in the nasal mucous membrane rupture. Typically, the anterior septum is the primary site of occurrence.
Etiology
Possible causes of this condition include high blood pressure, trauma, low humidity, upper respiratory tract infections, allergies, foreign bodies, nasal inhalation of corticosteroids or illicit drugs, excessive use of decongestant nasal sprays, facial or nasal surgery, anatomic malformation, tumors, or systemic...
864

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Remove Oral Diphenhydramine From OTC-End the Status Quo.

JAMA internal medicine·2026
Same author

Fatigue, interoplastic and nociplastic distress in myalgic encephalomyelitis/chronic fatigue syndrome, Gulf War Illness, and chronic idiopathic fatigue.

Frontiers in neuroscience·2025
Same author

Letter to the editor: author response for "why fexofenadine is considered as a truly non-sedating antihistamine with no brain penetration: a systematic review".

Current medical research and opinion·2025
Same author

Cerebrospinal fluid metabolomics, lipidomics and serine pathway dysfunction in myalgic encephalomyelitis/chronic fatigue syndroome (ME/CFS).

Scientific reports·2025
Same author

Exertional Exhaustion (Post-Exertional Malaise, PEM) Evaluated by the Effects of Exercise on Cerebrospinal Fluid Metabolomics-Lipidomics and Serine Pathway in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

International journal of molecular sciences·2025
Same author

Diphenhydramine: It is time to say a final goodbye.

The World Allergy Organization journal·2025
Same journal

Sebetralstat for on-demand treatment of hereditary angioedema: A pooled analysis of placebo-controlled clinical trials.

The World Allergy Organization journal·2026
Same journal

Long-term prophylaxis in hereditary angioedema: Real-world treatment patterns and healthcare resource utilization.

The World Allergy Organization journal·2026
Same journal

Erratum to "World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) Guidelines update - IV - A quality appraisal with the AGREE II instrument" [World Allergy Organ J 15(2) (February 2022) 100613].

The World Allergy Organization journal·2026
Same journal

Why physicians underuse patient-reported outcomes in atopic dermatitis and chronic urticaria - Insights from the UCARE/ADCARE PROMUSE study.

The World Allergy Organization journal·2026
Same journal

Prevalence of allergic diseases and evaluation of total IgE and blood eosinophils as diagnostic biomarkers in Colombia, a tropical country.

The World Allergy Organization journal·2026
Same journal

Characterization of hereditary angioedema population in Argentina: A nationwide study.

The World Allergy Organization journal·2026
See all related articles

Related Experiment Video

Updated: May 6, 2026

Author Spotlight: Advancing Allergic Rhinitis Research with Multicolor Immunofluorescence
06:08

Author Spotlight: Advancing Allergic Rhinitis Research with Multicolor Immunofluorescence

Published on: September 22, 2023

2.7K

Consensus Definition of Nonallergic Rhinopathy, Previously Referred to as Vasomotor Rhinitis, Nonallergic Rhinitis,

Michael A Kaliner1, James N Baraniuk, Michael Benninger

  • 1Institute for Asthma and Allergy, Chevy Chase, Md. jrfarrar@rochester.rr.com.

The World Allergy Organization Journal
|November 16, 2013
PubMed
Summary
This summary is machine-generated.

Nonallergic vasomotor rhinitis, now proposed as nonallergic rhinopathy, is a common nasal condition lacking clear diagnostic criteria. This terminology change aims to define patient populations for improved treatment research.

More Related Videos

Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis
03:40

Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis

Published on: December 20, 2024

1.9K
Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber
08:47

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber

Published on: March 3, 2023

3.9K

Related Experiment Videos

Last Updated: May 6, 2026

Author Spotlight: Advancing Allergic Rhinitis Research with Multicolor Immunofluorescence
06:08

Author Spotlight: Advancing Allergic Rhinitis Research with Multicolor Immunofluorescence

Published on: September 22, 2023

2.7K
Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis
03:40

Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis

Published on: December 20, 2024

1.9K
Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber
08:47

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber

Published on: March 3, 2023

3.9K

Area of Science:

  • Otolaryngology
  • Allergy and Immunology
  • Rhinology

Background:

  • Nonallergic vasomotor rhinitis (NAVR), also known as nonallergic rhinitis or idiopathic rhinitis, is a prevalent nasal disorder with poorly understood mechanisms.
  • Current diagnostic criteria for NAVR are not well-defined, hindering research into effective treatments.
  • The lack of standardized patient populations complicates clinical trials and therapeutic development.

Purpose of the Study:

  • To propose a revised terminology for nonallergic rhinitis, shifting from "nonallergic vasomotor rhinitis" to "nonallergic rhinopathy."
  • To establish clear inclusion and exclusion criteria for identifying homogeneous patient cohorts.
  • To facilitate more precise patient selection for clinical research and trials.

Main Methods:

  • A roundtable conference was convened in December 2008 involving expert discussion and debate.
  • The conference focused on addressing the limitations of existing terminology and diagnostic approaches.
  • Proposed new terminology and clinical characteristics were developed based on consensus.

Main Results:

  • A proposal was made to rename the condition "nonallergic rhinopathy."
  • Defined clinical characteristics for nonallergic rhinopathy were outlined, including symptom patterns (perennial, intermittent, seasonal) and triggers.
  • These characteristics provide a framework for well-defined inclusion and exclusion criteria.

Conclusions:

  • The proposed terminology "nonallergic rhinopathy" and its defined clinical characteristics offer a more precise approach to identifying patients.
  • This standardization is crucial for advancing research and developing targeted treatments for this nasal condition.
  • Improved patient stratification will enhance the validity and efficiency of clinical trials for nonallergic rhinopathy.